Publication | Closed Access

In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma

GliomaCd8 T CellsImmunologyTumor ImmunityVivo Crispr ScreeningT Cell ImmunityGene EditingGenome EditingImmune Cell TherapyImmunotherapyMedicineCell BiologyCrispr